Home›Search›Diabetes, Metabolic Syndrome and Obesity

Diabetes, Metabolic Syndrome and Obesity

Dove Medical Press Ltd · New Zealand · Est. 2008

ISSN1178-7007eISSN1178-7007

SJR Q2✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

100

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (4 more)+22

Total100

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to publish · journal-reported

Average · vs ~15 wk median

SJR Rank

Top 50% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.89

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.842

Total Worksi

3,428

Total Citationsi

64,333

2yr Mean Citednessi

2.80

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

The journal is committed to the rapid publication of the latest laboratory and clinical findings that lead to establishing new paradigms in the diagnosis, treatment or prevention of diabetes, metabolic syndrome, or obesity. The journal welcomes original research manuscripts, reviews, expert opinions, and commentaries relating to all aspects of obesity, diabetes, and metabolic syndrome.

General Information

Country / RegionNew Zealand

Primary LanguageEnglish

1st Year Published2008

Annual Volume~ 396 articles / year

StatusActive (last: 2026)

Total Publications3,428

Publisher OrgDove Medical Press

OA Since2007

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~16 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PMCCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

Dove Medical Press Ltd

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1178-7007 / 1178-7007

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

PMC, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

260

8.4k

2019

489

12k

2020

449

7.9k

2021

350

4.7k

2022

373

3.8k

2023

426

2.4k

2024

389

756

2025

153

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Internal MedicineQ2

PharmacologyQ2

Subject Classification

Web of Science Categories

Endocrinology & Metabolism

Scopus Categories

Internal MedicinePharmacology

Research Topics (OpenAlex)

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and ManagementAdipokines, Inflammation, and Metabolic DiseasesDiabetes Management and ResearchLiver Disease Diagnosis and TreatmentDiabetes Management and EducationChronic Kidney Disease and DiabetesMetabolism, Diabetes, and CancerBariatric Surgery and OutcomesDiet and metabolism studies

Frequently asked questions about Diabetes, Metabolic Syndrome and Obesity

Is Diabetes, Metabolic Syndrome and Obesity a predatory journal?

PubScope has no integrity flags on record for Diabetes, Metabolic Syndrome and Obesity: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Diabetes, Metabolic Syndrome and Obesity?

Diabetes, Metabolic Syndrome and Obesity is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.80.

Is Diabetes, Metabolic Syndrome and Obesity indexed in Scopus and Web of Science?

Diabetes, Metabolic Syndrome and Obesity is indexed in Web of Science, Scopus, DOAJ.